Sham Mailankody

38PUBLICATIONS
164CO-AUTHORS
Carbon capture engineering (excl. sequestration)Haematological tumoursMedical bacteriologyMolecular targetsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Oct 20, 2026
The EF1α promoter of cilta-cel drives a highly effective GZMK+ transcriptional program.

|Jul 29, 2026
Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma.

|Jul 20, 2026
Lenalidomide-Related Diarrhea in Patients with Multiple Myeloma Is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool.

|Jun 27, 2026
Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data.

|Jun 12, 2026
Genomic Features Do Not Account for Differences in Multiple Myeloma Risk by Ancestry.

|Apr 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma.

Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve

Pageof 7

Frequent Collaborators

24 joint publications

Urvi Shah

22 joint publications

Carlyn Tan

21 joint publications

Saad Z Usmani

21 joint publications

Sergio Giralt